ANDA Approval Records Will End As US FDA Mops Up Backlog

 
• By Derrick Gingery
Businessman looking through a magnifying glass to documents
Once the backlog is cleared, there may be fewer ANDAs for FDA to approve, which may mean records will not continue to be broken each year. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics